CUMBERLAND PHARMACEUTICALS
CPIX · NASDAQ
Updated at 2026-10-13 13:02:02
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $6.66
- Previous Close
- $7.00
- Volume
- 11.54K
- Market Cap
- $104.88M
- P/E Ratio
- --
- EPS
- $-0.72
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 1600 WEST END AVENUE, NASHVILLE, TN, UNITED STATES, 37203
- Country
- US
- Listing Date
- 2009-08-11
- Fiscal Year End
- December
- Shares Outstanding
- 14.98M
- CIK
- 0001087294
- Website
- www.cumberlandpharma.com
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company is headquartered in Nashville, Tennessee.
Financial Metrics
Revenue
2026-06-30
$166.45K
2026-03-31
$9.13M
2025-12-31
$13.67M
2025-09-30
$8.29M
Operating Expenses
2026-06-30
$3.28M
2026-03-31
$10.32M
2025-12-31
$12.8M
2025-09-30
$9.26M
Net Income
2026-06-30
-$4.11M
2026-03-31
-$3.13M
2025-12-31
-$1.41M
2025-09-30
-$1.94M
Net Profit Margin
2026-06-30
-2.47K%
2026-03-31
-34.36%
2025-12-31
-10.32%
2025-09-30
-23.4%
Earnings Per Share
2026-06-30
$-0.20
2026-03-31
$-0.21
2025-12-31
$-0.09
2025-09-30
$-0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.12M
2026-03-31
-$1.48M
2025-12-31
$47.84K
2025-09-30
-$510.68K
Effective Tax Rate
2026-06-30
-0.12%
2026-03-31
-0.12%
2025-12-31
-1.65%
2025-09-30
-0.29%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $166.45K | $9.13M | $13.67M | $8.29M |
| Operating Expenses | $3.28M | $10.32M | $12.8M | $9.26M |
| Net Income | -$4.11M | -$3.13M | -$1.41M | -$1.94M |
| Net Profit Margin | -2.47K% | -34.36% | -10.32% | -23.4% |
| Earnings Per Share | $-0.20 | $-0.21 | $-0.09 | $-0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.12M | -$1.48M | $47.84K | -$510.68K |
| Effective Tax Rate | -0.12% | -0.12% | -1.65% | -0.29% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.